Qing Song Health Co.,Ltd. (TPE:6931)
64.30
+0.90 (1.42%)
At close: Dec 19, 2025
Qing Song Health Market Cap
Qing Song Health has a market cap or net worth of 4.28 billion as of December 19, 2025. Its market cap has decreased by -29.43% in one year.
Market Cap
4.28B
Enterprise Value
4.71B
Revenue
1.08B
Ranking
n/a
PE Ratio
63.84
Stock Price
64.30
Market Cap Chart
Since December 27, 2022, Qing Song Health's market cap has increased from 2.32B to 4.28B, an increase of 84.52%. That is a compound annual growth rate of 22.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.28B | -27.20% |
| Dec 31, 2024 | 5.88B | 28.33% |
| Dec 29, 2023 | 4.58B | 120.52% |
| Dec 30, 2022 | 2.08B | -10.44% |
| Dec 27, 2022 | 2.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 238.84B |
| PharmaEssentia | 185.66B |
| Heron Neutron Medical | 84.35B |
| Lotus Pharmaceutical | 74.55B |
| Bora Pharmaceuticals Co., LTD. | 61.03B |
| Lin BioScience | 33.17B |
| Lumosa Therapeutics | 31.33B |
| Center Laboratories | 28.03B |